ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc (KPTI)

9,12
-0,53
(-5,49%)
Chiuso 25 Giugno 10:00PM
8,9635
-0,1565
(-1,72%)
Dopo le ore di negoziazione: 1:59AM

Karyopharm Therapeutics Inc (KPTI) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-05-14Mr. Stuart PoultonExec. VP & Chief Development Officer-403,003,83kVendita9,5094,82k-0,42%
2026-05-14Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research-408,003,88kVendita9,5056,83k-0,71%
2026-05-14Ms. Sohanya ChengExec. VP, Chief Commercial Officer & Head of Business Development-324,003,08kVendita9,50107,94k-0,30%
2026-05-14Ms. Kristin AbateVP, CAO & Assistant Treasurer-53,00503,50Vendita9,5023,80k-0,22%
2026-05-14Mr. Richard A. PaulsonPresident, CEO & Director-2,20k20,93kVendita9,50269,75k-0,81%
2026-05-14Mr. Michael J. ManoExec. VP, Chief Legal Officer & Secretary-266,002,53kVendita9,5094,40k-0,28%
2026-04-21Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research-449,004,01kVendita8,9412,47k-3,48%
2026-03-02Ms. Kristin AbateVP, CAO & Assistant Treasurer-559,005,26kVendita9,4122,06k-2,47%
2026-03-02Mr. Michael J. ManoExec. VP, Chief Legal Officer & Secretary-3,53k33,18kVendita9,4111,29k-23,81%
2026-03-02Ms. Sohanya ChengExec. VP, Chief Commercial Officer & Head of Business Development-4,60k43,32kVendita9,4120,93k-18,03%
2026-03-02Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research-5,07k47,67kVendita9,4112,92k-28,17%
2026-03-02Mr. Richard A. PaulsonPresident, CEO & Director-12,36k116,31kVendita9,4148,51k-20,31%
2026-03-02Mr. Stuart PoultonExec. VP & Chief Development Officer-5,10k48,00kVendita9,4112,01k-29,82%
2026-02-17Mr. Stuart PoultonExec. VP & Chief Development Officer-378,003,26kVendita8,636,11k-5,83%
2026-02-03Ms. Lori A. MacomberEVP, CFO & Treasurer-1,63k10,24kVendita6,301,93k-45,74%
2026-01-28Ms. Kristin AbateVP, CAO & Assistant Treasurer-50,00351,50Vendita7,0322,62k-0,22%
2026-01-21Ms. Kristin AbateVP, CAO & Assistant Treasurer-265,001,58kVendita5,9622,58k-1,16%
2025-10-01Ms. Kristin AbateVP, CAO & Assistant Treasurer-362,002,28kVendita6,3010,05k-3,48%
2025-09-15Mr. Richard A. PaulsonPresident, CEO & Director-1,26k8,08kVendita6,4333,95k-3,57%
2025-09-15Mr. Michael J. ManoExec. VP, Chief Legal Officer & Secretary-234,001,50kVendita6,436,70k-3,37%
2025-09-15Mr. Stuart PoultonExec. VP & Chief Development Officer-401,002,58kVendita6,436,49k-5,82%
2025-09-15Dr. Reshma RangwalaExec. VP, Chief Medical Officer & Head of Research-408,002,62kVendita6,437,24k-5,33%
2025-09-15Ms. Sohanya ChengExec. VP, Chief Commercial Officer & Head of Business Development-325,002,09kVendita6,4313,39k-2,37%
2025-09-15Ms. Kristin AbateVP, CAO & Assistant Treasurer-23,00147,89Vendita6,4310,41k-0,22%
2025-09-03Ms. Kristin AbateVP, CAO & Assistant Treasurer-12,0081,36Vendita6,789,46k-0,13%
2025-07-29Mr. Stuart PoultonExec. VP & Chief Development Officer-191,00834,67Vendita4,3727,22k-0,70%
2025-07-22Ms. Kristin AbateVP, CAO & Assistant Treasurer-238,00952,00Vendita4,009,48k-2,45%